MedPath

Prospective Randomized Study on the Effects of Valgus Knee Brace for Knee Osteoarthritis in Chinese Patients

Not Applicable
Conditions
Osteoarthritis, Knee
Interventions
Device: Valgus knee brace (Medex K39-OA Corrector)
Other: Physiotherapy and oral analgesic (diclofenac and panadol)
Registration Number
NCT04056845
Lead Sponsor
Hospital Authority, Hong Kong
Brief Summary

To investigate whether the use of valgus knee brace is useful for patients with medial knee osteoarthritis.

Detailed Description

Osteoarthritis of the knee is the commonest type of arthritis affecting both the middle age and geriatric population, which poses a huge burden to our in-patient and out-patient orthopaedic services. Conservative treatment like physiotherapy and analgesic provide temporary symptomatic relief. Surgical treatment like high tibial osteotomy and knee arthroplasty are not without major potential surgical risks and implant-related complications.

Orthotic treatment can theoretically alter the loading to the knee joint and help to reduce the symptoms and disease progression. Small scale biomechanical studies have demonstrated such effects with the use of valgus knee brace (2-4). Though prospective clinical outcome studies on Chinese patients in our locality are lacking.

Valgus knee brace is a non-pharmaceutical, non-invasive option for knee pain. Using a three-point leverage the unloader brace is to shift the stress away from the arthritic area to the normal portion of the knee, maintains good alignment and stability and thus provides significant pain relief during daily activities. It has been commonly used as a first line management option in other countries.

Our aim is to perform a prospective randomized study to look at the difference in outcome measures in osteoarthritic patients with the use of valgus knee brace, on top of the usual regime of conservative treatment.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Age between 40-80
  • History of symptomatic medial unicompartmental knee osteoarthritis > 6 months
  • Willingness to wear the knee brace for a minimum of 4 hours per day during daily activities
  • Understanding of the Chinese language
  • Ethnic Chinese patients
Exclusion Criteria
  • Symptomatic knee osteoarthritis affecting more than one compartment
  • Clinical and radiological signs of osteoarthritis over the lateral compartment or patello-femoral joint
  • Significant knee effusion or soft tissue compromise preventing long-term knee brace use
  • Obesity (BMI>30)
  • Previous surgery on the affected knee other than diagnostic arthroscopy with debridement, soft tissue reconstruction, menisectomy
  • Peripheral vascular disease of the lower limb

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Knee brace groupValgus knee brace (Medex K39-OA Corrector)Patients in this group will receive a valgus knee brace (Medex K39-OA Corrector), to be worn for at least four hours a day, during the study period, on top of the presrciption of physiotherapy and oral analgesic (diclofenac and panadol).
Knee brace groupPhysiotherapy and oral analgesic (diclofenac and panadol)Patients in this group will receive a valgus knee brace (Medex K39-OA Corrector), to be worn for at least four hours a day, during the study period, on top of the presrciption of physiotherapy and oral analgesic (diclofenac and panadol).
Control GroupPhysiotherapy and oral analgesic (diclofenac and panadol)Patients in this group will receive physiotherapy and oral analgesic (diclofenac and panadol).
Primary Outcome Measures
NameTimeMethod
Improvement in painAt 16 weeks after the initiation of study

Visual Analog Scale (VAS) for pain from 0 to 10, with higher value signifying worse pain control

Secondary Outcome Measures
NameTimeMethod
Improvement in knee functioningAt 16 weeks after the initiation of the study

The Western Ontario and McMaster Universities Osteoarthritis Index

Trial Locations

Locations (1)

Hospital Authority

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath